Related Experiment Video
Updated: Jun 30, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies
Charles J Diskin1, Thomas J Stokes, Linda M Dansby
1Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA. hndt512@bellsouth.net
Insights
Maintaining vascular access for hemodialysis is crucial. Understanding complications like thrombosis and infection can lead to new prevention and treatment strategies for better patient outcomes.
Area of Science:
- Nephrology and Vascular Surgery
- Biomedical Engineering
- Infectious Diseases
Background:
- Vascular access is essential for hemodialysis, but its maintenance presents significant challenges.
- Complications include thrombosis, stenosis, aneurysm formation, fistula maturation failure, and catheter infection.
- Improved understanding of pathophysiology is needed for innovative prevention and treatment strategies.
Purpose of the Study:
- To explore novel therapeutic targets for preventing and treating vascular access complications in hemodialysis.
- To identify agents that enhance fistula maturation and graft survival.
- To investigate methods for preventing catheter-related infections.
Main Methods:
- Review of observational studies on vascular access complications.
- Analysis of potential therapeutic agents targeting inflammation, endothelial function, and smooth muscle cell proliferation.
- Exploration of metalloproteinase inhibitors and bacterial quorum sensing inhibitors.
Main Results:
- Agents reducing inflammation and improving endothelial function may enhance fistula and graft survival by mitigating thrombosis and stenosis.
- Metalloproteinase inhibitors show potential in preventing aneurysm formation.
- Bacterial quorum sensing inhibition is a promising strategy against catheter biofilm infections.
Conclusions:
- Targeting inflammatory pathways, endothelial function, and vascular smooth muscle cell behavior can improve hemodialysis access longevity.
- Pharmacological interventions against metalloproteinases and bacterial quorum sensing offer new avenues for managing access complications.
- Further research into these mechanisms can lead to improved patient care and outcomes in hemodialysis.
Abstract:
Maintenance of a functioning vascular access for hemodialysis is a major challenge for nephrologists, vascular surgeons and--most importantly--the patients themselves. Greater insight into the pathophysiology of access thrombosis, stenosis, aneurysm formation, fistula maturation failure and catheter infection will aid the development of innovative ways to prevent and treat these complications. According to the results of observational studies, agents that decrease the release of inflammatory mediators, improve endothelial function, and inhibit the migration and proliferation of vascular smooth-muscle cells might improve the maturation and survival of native hemodialysis fistulas and synthetic hemodialysis grafts by reducing the risks of thrombosis and stenosis. Currently available drugs that interfere with metalloproteinases could prevent the formation of aneurysms, and bacterial quorum sensing offers a promising target for the prevention of biofilm infection in hemodialysis catheters.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Acute Kidney Injury V: Interprofessional Care

